3 min read
Home >
Blog
Blog | Veristat
Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.
Sign Up Today
Regulatory Submissions (13)
3 min read
Regulatory Guidance Monthly Review - October 2019
November 6, 2019
October 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug,...
4 min read
Regulatory Guidance Monthly Review - September 2019
October 2, 2019
September 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug,...
3 min read
Regulatory Guidance Monthly Review - August 2019
September 3, 2019
August 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug,...
2 min read
Regulatory Guidance Monthly Review - July 2019
August 2, 2019
July 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic,...
2 min read
Regulatory Guidance Monthly Review - June 2019
July 10, 2019
June 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic,...
2 min read
Regulatory Guidance Review - May 2019
June 6, 2019
May 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) and European Medicines Agency (EMA) that are pertinent to the governance of...
2 min read
Regulatory Guidance Review - April 2019
May 8, 2019
Latest Updates from FDA & EMA
April 2019 Updates
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) and European Medicines Agency (EMA) that are pertinent...
2 min read
Regulatory Guidance Review
March 28, 2019
Latest Updates from FDA & EMA
March 2019
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) and European Medicines Agency (EMA) that are pertinent to the...
3 min read
Is Your Complex NDA/MAA Submission Missing One of These Key Elements?
August 21, 2018
Veristat has experience in preparing more than 120 marketing applications. Our exposure to in creating new drug applications (NDAs) and marketing authorization applications (MAAs) has taught us two main lessons: